2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

Circulation. 2020 Dec 22;142(25):e558-e631. doi: 10.1161/CIR.0000000000000937. Epub 2020 Nov 20.
No abstract available

Keywords: AHA Scientific Statements; atrial fibrillation; cardiovascular magnetic resonance; diastolic dysfunction; echocardiography; exercise stress testing; family screening; genetics; guidelines; hypertrophic cardiomyopathy; implantable cardioverter defibrillator; left ventricular outflow tract obstruction; occupation; physical activity; pregnancy; rhythm monitoring; risk stratification; sarcomeric genes; septal alcohol ablation; septal reduction therapy; shared decision-making; sudden cardiac death; surgical myectomy; systolic dysfunction; ventricular arrhythmias.

Publication types

  • Practice Guideline
  • Review

MeSH terms

  • Algorithms
  • American Heart Association
  • Cardiac Imaging Techniques / standards*
  • Cardiology / standards*
  • Cardiomyopathy, Hypertrophic / diagnostic imaging*
  • Cardiomyopathy, Hypertrophic / therapy*
  • Consensus
  • Decision Support Techniques
  • Evidence-Based Medicine / standards
  • Humans
  • Predictive Value of Tests
  • Treatment Outcome
  • United States